Andrew Ng’s AI Fund Marks Maiden India Bet With AI Healthcare Startup Jivi

AI Fund, a venture studio led by computer scientist and artificial intelligence research pioneer Andrew Ng, has marked its maiden bet in India by backing healthcare startup Jivi AI.

However, the financial transactions of the deal were not disclosed.

The fund will come on board as a cofounder of the Gurugram-based Jivi AI, alongside Ankur Jain, former chief product officer at BharatPe and GV Sanjay Reddy, chairperson of Reddy Ventures.

Founded in 2023, Jivi AI combines AI-powered diagnostics with human validation from leading doctors, guiding patients through the journey of diagnosis, treatment, and preventive care. 

The startup creates personalised health reports that include symptoms, potential diseases, and treatment options — based on millions of medical journals and years of research. 

As per Jivi AI’s website, it is led by an interdisciplinary team of physicians, data scientists, engineers, and designers, coming from Ivy League colleges, “all working towards leveraging AI to transform healthcare”. 

“AI is transforming healthcare, and Jivi takes an important step toward more equitable, precise, and personalized care. Ankur and team are at the forefront of this transformation and are developing accessible and intelligent tools. AI Fund is excited to advance this vision together with Jivi,” said Andrew Ng.

The AI healthcare space in India has been gaining a lot of traction from investors for quotes sometime now.

For Instance, last month, healthcare startup Qure.ai raised $65 Mn (INR 543 Cr) in a Series D funding round co-led by Lightspeed Venture Partners and 360 ONE Asset Management. 

Meanwhile in August, medtech startup SigTuple raised $4 Mn (over INR 33.5 Cr) in an extended Series C funding round led by Sidbi Venture Capital to ramp up its product portfolio and expansion efforts.

In the same month, online healthcare service provider Visit Health secured INR 250 Cr (nearly $29.8 Mn) from PB Fintech’s arm, Docprime Technologies, through a mix of capital infusion and secondary share purchase.

India’s medtech industry is also undergoing a significant transformation driven by digital health adoption, AI integration, and the rise of wearable technology. AI is revolutionising medical diagnostics and treatment, with startups and large firms investing heavily in this space.

Note: We at Inc42 take our ethics very seriously. More information about it can be found here.